🇺🇸 FDA
Patent

US 11096927

Anti-flavivirus compounds and methods of use

granted A61KA61K31/165A61K31/245

Quick answer

US patent 11096927 (Anti-flavivirus compounds and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/165, A61K31/245, A61K31/336, A61K31/352